Save time and get answers to complex questions with AI chat
Dabrafenib mesylate when the patent is expiring in india?When will latisse patent expire?Zemdri nce gain exclusivity 2028 patent 2031?Pramlintide acetate price?Xiaflex market launch year?
See the DrugPatentWatch profile for warfarin
Warfarin, a vitamin K antagonist that thins blood by inhibiting clotting factors, interacts with Lipitor (atorvastatin), a statin used to lower cholesterol. Atorvastatin can inhibit CYP3A4 enzymes that metabolize warfarin, potentially raising its blood levels and INR (international normalized ratio), which measures clotting time. This increases bleeding risk, especially at higher Lipitor doses (e.g., 40-80 mg daily).[1][2]
Contact a doctor immediately for unusual bleeding, black stools, severe headache, or weakness. Antidotes like vitamin K or PCC (prothrombin complex concentrate) may be needed for serious over-anticoagulation.[3]
If interaction causes issues, consider: - Switching statin to pravastatin or rosuvastatin (weaker CYP3A4 inhibitors). - Direct oral anticoagulants (DOACs) like apixaban over warfarin for eligible patients, avoiding this interaction.[4] | Drug Pair | Interaction Risk | Typical INR Change | |-----------|------------------|-------------------| | Warfarin + Atorvastatin 10-20 mg | Low-moderate | +0.2-0.5 units | | Warfarin + Atorvastatin 40-80 mg | Moderate-high | +0.5-1.5 units[2][5] | Sources [1]: FDA Lipitor Label [2]: Lexicomp Interaction Checker [3]: UpToDate: Warfarin Management [4]: ACC Expert Consensus on Anticoagulation [5]: PubMed: Statin-Warfarin Interactions
Other Questions About Warfarin :